COVID-19 remains a threat, particularly to some groups such as transplant recipients and other immunosuppressed people. This research study will help scientists and the Government assess the effectiveness of the third COVID-19 vaccination or “booster” vaccination programme among immunosuppressed people. A 6 month follow up will see how many Covid infections have been reported in the trial groups. If you’ve had a solid organ transplant (e.g. lung, liver, kidney), are taking medication to suppress your immune system and have received your third COVID-19 vaccination or “booster” vaccination, you can register to take part. Visit www.melodystudy.org to find out more about...
Our amazing supporter Aimee, whose daughter Harper has CF, hosted a FeBREWary tea party last year, raising an incredible £1,500. Here, Aimee talks about Harper’s journey with CF and why she’s encouraging others to get involved in FeBREWary 2022.
We welcome the news that new antiviral and antibody treatments will be made available for people post-transplant and most vulnerable to COVID-19, who have had a positive PCR test. And for anyone with cystic fibrosis (CF) over 18, there is also the opportunity to take part in an antiviral treatment trial after testing positive for COVID-19.
People with CF who are post-transplant and have received at least their third COVID-19 vaccine dose will be able to participate in a new MELODY study announced today.
Following the exciting announcement of a new national study into the effectiveness of COVID-19 vaccines for people with weaker immune systems, Vicky Pettersen, who had a double lung transplant over 20 years ago, shares her story and reflects on the impact the pandemic has had on her life.
